Log In
BCIQ
Print this Print this
 

SENS-300

  Manage Alerts
Collapse Summary General Information
Company Sensorion S.A.
Description 
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPreclinical
Standard IndicationHearing loss
Indication DetailsPrevent drug-induced ototoxicity
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today